Anti-NOVA2 Antibody
Overview
This antibody is raised against a protein sequence from human NOVA2 (neuro-oncological ventral antigen 2), an RNA-binding protein involved in alternative splicing regulation, particularly in neuronal tissues. It is supplied as part of the Atlas Antibodies Triple A Polyclonals portfolio and is intended for detection of endogenous NOVA2 in human tissue samples. The manufacturer reports validation of this antibody for immunohistochemistry applications.
Highlights
- Antibody targeting human neuro-oncological ventral antigen 2 (NOVA2)
- Validated application: immunohistochemistry (IHC)
- Immunogen derived from a defined NOVA2 protein sequence
- Supplied in a glycerol-containing phosphate buffer formulation
At-a-glance
- Target protein
- NOVA2 (neuro-oncological ventral antigen 2)
- Host species
- Rabbit
- Clonality
- Polyclonal
- Validated applications
- Immunohistochemistry (IHC)
- Immunogen sequence
- GFLTAEKLAAESAKELVEIAVPE
- Buffer composition
- 40% glycerol, PBS (pH 7.2), 0.02% sodium azide
- Condition
- New / Unused — The product is only validated for IHC application
Applications
This antibody is suitable for immunohistochemical detection of NOVA2 in human tissue sections. It may be used in research examining neuronal RNA splicing regulation and neurodevelopmental processes. Validation is not reported for applications beyond immunohistochemistry.
Sustainability
By rehoming surplus lab products, this listing supports waste reduction and resource efficiency.
